Literature DB >> 32190637

Misdiagnosis of primary intimal sarcoma of the pulmonary artery as chronic pulmonary embolism: A case report.

Ping Lu1, Bei-Bei Yin2.   

Abstract

BACKGROUND: Primary intimal sarcoma of the pulmonary artery is a rare malignant tumor originating from the pulmonary artery, which has a low incidence rate and is easily misdiagnosed as pulmonary embolism. There is no standard protocol for the treatment of primary intimal sarcoma of the pulmonary artery. CASE
SUMMARY: This study reports a patient with primary intimal sarcoma of the pulmonary artery who was admitted to our hospital in 2017. The clinical characteristics, diagnosis, treatment and outcome of the patient were retrospectively analyzed. The patient was a Chinese Han male aged 44 years. He had three consecutive episodes of syncope, and was thus admitted to a local hospital. Computed tomography pulmonary angiography showed multiple lesions with abnormal densities in the pulmonary trunk, left pulmonary artery, mediastinum and pericardium, which were consistent with recurrence after tumor resection. He underwent surgery, and was pathologically diagnosed with intimal sarcoma of the pulmonary artery. He relapsed 3 mo after surgery, and apatinib was administered. His condition was stable after 4 mo, with tolerable and controllable adverse reactions. He subsequently died 19 mo after surgery.
CONCLUSION: Primary intimal sarcoma of the pulmonary artery has no specific clinical or imaging manifestations. The diagnosis of this disease depends on histopathology and immunohistochemistry, and has a poor clinical prognosis. Surgical treatment is currently a favorable option for primary intimal sarcoma of the pulmonary artery, and targeted therapy may provide new insights for the development of effective treatment methods. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Intimal sarcoma; Misdiagnosis; Pulmonary artery; Pulmonary embolism

Year:  2020        PMID: 32190637      PMCID: PMC7062609          DOI: 10.12998/wjcc.v8.i5.986

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  21 in total

1.  Intimal sarcoma of the pulmonary artery with retrograde extension into the pulmonic valve and right ventricle.

Authors:  Cengiz Ozbek; Bilgin Emrecan; Aylin Orgen Calli; Ali Gurbuz
Journal:  Tex Heart Inst J       Date:  2007

2.  Novel mutation of the cyclin-dependent kinase 4 gene in a Chinese patient with intimal sarcoma of the pulmonary artery.

Authors:  Feng Gao; Qi-cai Liu; Mi Wang; Zhi-qiang Wang; Yi Huang; Xiao-hui Zhou; Sheng Zhang
Journal:  Chin Med J (Engl)       Date:  2009-05-05       Impact factor: 2.628

Review 3.  Pulmonary artery sarcomas: a review of clinical and radiologic features.

Authors:  J E Cox; C Chiles; S L Aquino; P Savage; T Oaks
Journal:  J Comput Assist Tomogr       Date:  1997 Sep-Oct       Impact factor: 1.826

4.  A case of intimal sarcoma of the pulmonary artery successfully treated with chemotherapy.

Authors:  Yanjie Xu; Kai Wang; Yiting Geng; Yongfeng Shao; Yongmei Yin
Journal:  Int J Clin Oncol       Date:  2011-10-27       Impact factor: 3.402

5.  Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study.

Authors:  Baorang Zhu; Jing Li; Qiaosheng Xie; Liyan Diao; Lvhua Gai; Wuwei Yang
Journal:  Cancer Biol Ther       Date:  2018-01-24       Impact factor: 4.742

6.  Pulmonary artery sarcoma mimicking massive pulmonary embolus: a case report.

Authors:  Bahaaldin Alsoufi; Matthew Slater; Pamela P Smith; Tara Karamlou; Atiya Mansoor; Pasala Ravichandran
Journal:  Asian Cardiovasc Thorac Ann       Date:  2006-08

7.  Primary pulmonary artery sarcoma: report of three cases and review of the literature.

Authors:  Luis Manso; Elena Alvarez; Miguel Quintela; Hernan Cortes-Funes; Ricardo Hitt
Journal:  Clin Lung Cancer       Date:  2007-01       Impact factor: 4.785

8.  Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapy.

Authors:  Nicolas Penel; Sophie Taieb; Luc Ceugnart; Eric Dansin; Dominique Hoguet; Luc Vanseymortier; Eric Lartigau
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

Review 9.  Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.

Authors:  Giandomenico Roviello; Andrea Ravelli; Karol Polom; Roberto Petrioli; Luigi Marano; Daniele Marrelli; Franco Roviello; Daniele Generali
Journal:  Cancer Lett       Date:  2016-01-18       Impact factor: 8.679

10.  Pulmonary embolism caused by intimal sarcoma of the pulmonary artery.

Authors:  Kei Yamamoto; Tsuyoshi Nozue; Masayuki Tsuchida; Taku Iwaki; Hiroshi Nagamine; Tamotsu Yasuda; Hiroshi Kawase; Kazuhiko Matsushita; Ichiro Michishita
Journal:  Intern Med       Date:  2012-11-01       Impact factor: 1.271

View more
  5 in total

1.  Radiological, histopathological findings, and clinical outcome of pulmonary artery sarcoma.

Authors:  Shuai Zhang; Yu Zhang; Min Liu; Xincao Tao; Wanmu Xie; Jun Wan; Zhenguo Zhai
Journal:  Pulm Circ       Date:  2021-01-07       Impact factor: 3.017

2.  Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations.

Authors:  Chiao-En Wu; Ca Tung Ng; Kien Thiam Tan
Journal:  J Pers Med       Date:  2021-04-29

3.  A case report of primary cardiac intimal sarcoma presenting with atrial fibrillation and a left atrial mass.

Authors:  Karen Ho; Kavya Yatham; Rommel Seno; Omar Sultan
Journal:  Eur Heart J Case Rep       Date:  2021-10-07

4.  Pulmonary thromboembolic disease or pulmonary artery intimal sarcoma: Case report and literature review.

Authors:  Nan Shao; Chaosheng Deng
Journal:  Oncol Lett       Date:  2022-08-19       Impact factor: 3.111

5.  Clinicopathological features of pulmonary artery and vein intimal sarcomas: case series of rare pulmonary vessel intimal sarcoma.

Authors:  Hong-Qun Wang; Ai-Qun Sun; Peng Liu; Wei Chen; Chen Cao; Xin Song; Zhi-Gang Song
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.